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Abstract
The past decade, membrane signaling lipids emerged as major regulators of ion channel function. 
However, the molecular nature of lipid binding to ion channels remained poorly described due to a 
lack of structural information and assays to quantify and measure lipid binding in a membrane. 
How does a lipid-ligand bind to a membrane protein in the plasma membrane and what does it 
mean for a lipid to activate or regulate an ion channel? How does lipid-binding compare to 
activation by soluble neurotransmitter? And how does the cell control lipid agonism? This review 
focuses on lipids and their interactions with membrane proteins, in particular ion channels. I 
discuss the intersection of membrane lipid biology and ion channel biophysics. A picture emerges 
of membrane lipids as bona fide agonists of ligand-gated ion channels. These freely diffusing 
signals reside in the plasma membrane, bind to the transmembrane domain of protein, and cause a 
conformational change that allosterically gates an ion channel. The system employs a catalog of 
diverse signaling lipids ultimately controlled by lipid enzymes and raft localization. I draw upon 
pharmacology, recent protein structure, and electrophysiological data to understand lipid 
regulation and define inward rectifying potassium channels (Kir) as a new class of PIP2 lipid-gated 
ion channels.
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1. Introduction
Signaling lipids are important regulators of ion channels and exert a central role in tissue 
function including functional heartbeat, neuronal signaling, kidney dialysis, sight, smell, 
pain, and touch [1–5]. In the past, most biochemist and ion channel experts viewed lipids as 
unwieldy, hydrophobic molecules physically supporting ion channels in a cell membrane or 
liposomes but not as ligands. Recent past models of lipid signaling to ion channels suggested 
that the formation of anionic lipids caused a change in the plasma membrane surface charge. 
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Little was known about how lipids engaged and disengaged the channel or how the contact 
of a lipid with protein might affect the conformation of ion channels in the membrane. A 
lack of binding constants for lipids and ion channels challenged our ability to think about 
lipids as ligands. Aspects of this problem remain an important hurdle.
In 1998 Hilgemann and colleagues eloquently showed that a signaling lipid could directly 
activate an ion channel [6]. The lipid, phosphatidylinositol 4,5-bisphosphate (PIP2), a minor 
constituent of the plasma membrane, was required and sufficient for the activation of a 
potassium channel [6]. Despite more than a decade of experimentation, the nature of PIP2 
binding remained clouded by an inability to accurately measure its concentration in the 
membrane and directly detect binding to protein. Simple terminology such as lipid 
concentration and affinity are difficult to define for insoluble molecules in an aqueous 
environment [7]. Absent a well-characterized ligand protein interaction; initial non-specific 
theories of surface charge and membrane curvature dominated [8,9] but struggled to account 
for the specificity of signaling lipids in many systems. Recently a more accurate model 
emerges that includes structural and pharmacological evidence that lipids bind to and 
activate ion channels analogous to classic ligand-like agonist properties [10,11].
Herein a model of lipid agonism is built on PIP2 and inward rectifying potassium (Kir) 
channels. Aspects of many other classes of channels and signaling lipids appear to function 
in a similar way; select examples are included throughout this review. The intent of this 
review is to facilitate an understanding at the interface of ion channel activation and 
membrane lipid biology, although neither field is reviewed in a comprehensive way.
2. The signaling lipid PIP2 is an agonist that gates ion channels
PIP2, arguably the best-studied signaling lipid, is comprised of an inositol head group (the 
named feature) a phosphoglycerol backbone, and two acyl chains (Fig. 1A). PIP2 bears four 
negative charges and is a permanent and minor component (<1%) of the Eukaryotic plasma 
membrane inner leaflet [12,13].
2.2 PIP2 ion channel physiology
PIP2 signaling dictates the activatable state of a plethora of ion channels [2,14,15] (Fig. 1) 
with broad reaching cellular function. The first indication that a channel is PIP2 dependent 
usually arises when a channel, excised from the plasma membrane (e.g. inside out patch), 
steadily decreases in conductance until the channel inactivates, this is known as “rundown” 
[2,16]. The excised patch lacks the cytosolic factors to maintain sufficient PIP2 levels in the 
membrane to support ion channel function; hence the channels in the patch close. Adding 
ATP and Mg was shown to delay rundown [16]. Presumably, PIP2 synthesizing enzymes are 
excised in the patch with the channels and that these enzyme utilize the ATP to replenish 
PIP2 [2,16]. Adding back a soluble PIP2 analog dioctanoyl PIP2 (C8PIP2) rescues activity 
[2,15] of many ion channel types [17–20]. In a second method, PIP2 scavengers (e.g. 
polyamines or PIP2 antibodies) are used to deplete or mask PIP2 availability [21–23]. 
Polyamines are positively charged polymers that bind via avidity to the multiple negative 
charges of PIP2. More complete descriptions of PIP2 dependent ion channels and PIP2 
cellular function are reviewed by Suh and Hille [2,11], Xie [5], and McLaughlin [9]. 
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Recently, a voltage sensitive phosphatase (Ci-VSP) was shown to provide direct control 
over PIP2 signaling in the membrane [24–26]. When Ci-VSP is co transfected with Kir [24–
26], Kv7.1 [27], Cav2 [28,29], and TRP [30,31], channels are voltage dependent consistent 
with Ci-VSP regulation of PIP2. This method provides better control of PIP2; however, 
indirect effects of PIP2 remain a possibility.
In order to directly show PIP2 modulation, an ion channel can be purified and reconstituted 
(reinserted) into lipid vesicles with a known lipid composition. A lack of purified ion 
channels limited this technique, but recent advancements in membrane protein expression 
and purification [32,33] has overcome this problem for select channel types [34–38]. The 
nAChR was among the first channels to show direct dependence on a lipid for activation, 
phosphatidic acid (PA) [39]. Recently PIP2 dependent channels were reconstituted into lipid 
vesicles and shown to respond directly to PIP2 modulation, this includes GIRK [40,41], 
TRPV1 [42], TRPM8 [43], and Kir2.1-2 [44] channels.
2.3 PIP2 ion channel structure
Despite robust channel modulation by indirect methods, absent a crystal structure, an 
understanding of the molecular action of PIP2 and the precise binding site remained 
speculative. In 2011 an X-ray crystal structure complex of Kir2.2 with PIP2 revealed a PIP2 
binding site in the channel’s transmembrane domain [10] (Fig. 2). The glycerol backbone 
and 1′ phosphate of PIP2 capped the first transmembrane spanning helix (TM1) of Kir. 
Intimate coordination of the 5′ inositol phosphate in the distal end of the second 
transmembrane spanning helix (TM2) accounted for PIP2 specificity. And a conformational 
change appeared to initiate or open the ion conduction pathway. Basic residues on a linker 
between the transmembrane domain and cytoplasmic domain directly contacted PIP2, but 
distal basic residues proposed in the CTD [45] did not, rather they were buried and 
stabilized proper folding of the cytoplasmic domain structure [10]. Prior to the Kir2.2/PIP2 
complex, structures of PIP2/protein complexes were limited to soluble membrane 
localization domains, which lack a transmembrane domain and share few if any functional 
similarities with ion channels. A lack of appropriate structural examples and an 
understanding of how lipids and proteins interact in the plasma membrane hindered a 
complete mechanistic interpretation of PIP2 data. Furthermore, early studies on the C-
terminus of Kir included residues that turned out to be in the TMD of Kir and key to binding 
the 5′ inositol phosphate [6] (Fig. 2). Only with recent structural data has a model emerged 
where lipids bind to specific sites in the transmembrane domain of ion channels [10,46–49].
2.4 Lipid-gating theory
Taken together these finding suggest a ligand-gating theory of PIP2 activation. In 
biochemistry, the term ligand refers to the reversible, specific, and dose dependent binding 
of a substance to a protein to form a complex. Ligands include small molecule drugs, 
hormones, peptides, and metabolites. Normally ligands stabilize at least two states, one 
bound and one unbound [50,51].
The binding of PIP2 to Kir has many features of a ligand. First, PIP2 is in low abundance 
[9,12]. This requires that PIP2 bind with high affinity to its targets to exert an effect. Second, 
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PIP2 binds reversibly to ion channels in a dose dependent manner [20,23]. Third, PIP2 binds 
with specificity; for example, PI(4,5)P2 activates Kir2.1 and PI(3,4)P2 inhibits the same 
channel [52]. This specificity is striking since the two lipids are chemical isomers and only 
differ in the position of the 5′ phosphate. Another anionic lipid, oleoyl-CoA, competitively 
and reversibly inhibits all Kir’s [52] except Katp, which is specifically activated by oleoyl-
CoA [53,54]. Fourth, like neurotransmitter, PIP2 is a dynamically regulated molecule 
[55,56]; a signaling cascade can rapidly change the concentration of PIP2 to cause the 
channels to open or close [57–59]. And lastly, PIP2 channel affinity determines channel 
function [60]. Mutations that allosterically decrease the affinity of PIP2 cause disease (e.g., 
Andersen-Tawil syndrome) [45,61].
The ligand-like characteristics of PIP2 binding to the entire family of inward rectifiers 
warrant classification of these channels as ligand-gated. The unique properties of lipids 
logically give rise to a lipid subclass suggested here “lipid-gated” ion channels.
3. The evolving view of PIP2
3.1 Membrane surface charge theory
PIP2 was first speculated to induce ion channel activation by non-specific avidity of 
negatively charged phospholipid binding to clusters of basic amino acids in the C-terminus 
of channels [2,5,8]. Anionic lipids were thought to accumulate on the inner leaflet and non-
specifically attract positively charged residues on the surface of Kir’s cytoplasmic domain 
(CTD). The rational for the theory is sound and was based on data from Katp (Kir7.x) 
[21,62–64] and proteins like MARCKS [2,8]. However, in light of the PIP2/Kir complexes, 
the previous role of electrostatic theory appears inadequate for Kir. The glycerol backbone 
of PIP2 bound tightly to the transmembrane domain (TMD), and the inositol phosphates 
interacted with residues in or proximal to the TMD, not the CTD. The original influential 
lack of Katp’s specificity is an anomaly among Kir’s and appears to be an adaptation that 
allowed regulation by oleoyl-CoA [20] and not a mechanistic requirement as speculated. If 
non-specific anionic interactions regulate Kir, the site of anion lipid binding are likely distal 
to the canonical PIP2 site [65] or act synergistically with PIP2 [44,66] by binding to one of 
the 4 canonical sites. The notion that the cytoplasmic domain is the binding site for PIP2 and 
that PIP2 localizes the CTD similar to a PH domain appears to be incorrect. The Kir2.2 CTD 
did move toward the membrane and may reflect an evolutionary origin; but the primary 
mechanism appears to be an allosteric conformational change, not non-specific electrostatic 
attractions of the CTD to the membrane surface. The key PIP2 binding interactions were 
confirmed in a complex of PIP2 with GIRK2 [48] suggesting a common mechanism in 
related Kirs (Fig. 2B).
Voltage activated ion channels better exemplify non-specific electrostatic interaction. A well 
studied domain called the “voltage sensor domain” (VSD) senses and responds to changes in 
surface charge [33,47,67,68]. Conserved basic residues in the VSD electrostatically move 
towards the charge causing a conformational change that gates the channel. The charge is 
non-specific and can be applied by external current or by changing the charge of lipids in the 
plasma membrane. The latter was shown in recent bilayers studies where Kv responded 
symmetrically and non-specifically to anionic lipids [69]. The same study showed a distinct 
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phosphatidic acid site in the cytoplasmic leaflet that specifically and dramatically affected 
Kv gating [69]. This suggests both ligand and electrostatic modes can operate in the same 
channel, however the structural determinants of the two are likely distinct. A similar 
arrangement exists in Cav2, which has a voltage sensor and a putative PIP2 specific binding 
site [11,70].
Few other channels currently have sufficient molecular description to definitively 
discriminate the mechanism of action seen in Kir and Kv. Many tetrameric channels exhibit a 
C-terminal charged cluster and varying degrees of specificity reminiscent of Kir, including 
TRP [19,42,71–75], and P2X4 [76,77] (see table 1). Typically, these charges immediately 
follow or are located in the last transmembrane domain. Many other channels respond to 
PIP2 in ways that parallel Kir responses, including Cav [70], NMDA [78], Kv [27], P2X1-3 
[79] channels (see also Fig. 1C), but it is unknown if the interactions are direct with the 
TMD or indirect through membrane charge or other proteins. Since numerous soluble 
domains use polybasic clusters to target to the plasma membrane [80], some yet undefined 
cytoplasmic domains could utilize a membrane surface charge as previously speculated 
[2,8]. Future structural studies will continue to reveal the details and breadth of electrostatic 
theory.
3.2. Cofactor theory
Lipids are sometimes viewed as co-factors. Before discussing PIP2 as a cofactor I must first 
define a cofactor and distinguish it from a ligand. The term cofactor stems from enzymology 
and generally refers to a permanent organic compound or metal that is required for the 
enzyme to function. A cofactor normally derives its function by remaining bound to a 
protein. In contrast, a ligand derives its function by binding and dissociating from its partner 
protein. Lipids have always existed in cells and it is reasonable to assume that some lipids 
may bind as cofactors. A crystal structure of Kv in a lipid like environment revealed 
phospholipid binding sites near the voltage sensor and some of these appear to be lipid 
cofactors [47]. In other words they facilitate the proper organization of the channel but at 
present they do not appear to initiate a change in the channel state by dynamic regulation of 
the lipid.
In a speculative role, PIP2 was proposed to act as a ‘coincidence detector’ in order to 
facilitate transport of an inactive channel [2,15,81,82]. A nascent channel in the endoplasmic 
reticule (ER), where PIP2 is scarce, remains inactive until it arrives, at the plasma membrane 
where an abundance of PIP2 constitutively activates the ion channel. This fits well a 
definition of cofactor in the resting state. Directly demonstrating the physiological 
contribution remains a challenge since PIP2 is dynamically regulated [2]. For example PLC 
hydrolysis of PIP2 in the plasma membrane inhibits Kir [58,59], a function also consistent 
with ligand-like properties.
In another speculative role, PIP2 might function as a cofactor in sensing protons. The pka’s 
of inositol phosphates are around 6.5 and 6.9, an optimal range for sensing physiological 
changes in proton concentration [83]. The lipid could remain bound and simply supply the 
metal phosphate as a proton sensing cofactor. Ions interacting with lipids were recently 
shown to regulate a receptor [84]. Acid sensing ion channels (ASIC) are likely candidates 
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for such a mechanism since they bind PIP2 and sense protons. Alternatively, PIP2 may serve 
as a proton sensitive ligand. An atomic structure is known for ASIC [38] but the role of PIP2 
in channel activation requires further investigation.
Perhaps one reason for a slow adaptation of a “lipid-gating” model for PIP2 is the fact that 
the prototypical PIP2 gated channel Kir is active during the resting state of excitable cells. 
These channels are often considered “constitutively active” leak channels. While it is true 
they allow potassium out of the cell during the resting state, acetylcholine stimulation of M1 
muscarinic receptor inactivates Kir [58,59]. An early study on high affinity Kir2.1 in oocytes 
showed resistant to ACh inactivation [60], but later studies in mammalian cells 
demonstrated robust and complete inhibition of Kir2.1 through activation of M1 receptor 
[59]. Thus neurotransmitter induced closure of Kir potassium channels is presumably 
synergistic with the opening of calcium, sodium and voltage-gated channels, and should 
result in a stronger action potential or sustained excitability.
4. Cellular regulation of PIP2 agonism
The agonist properties of lipids broaden the cell-signaling role of PIP2 regulation. Similar to 
neurotransmitter, the release, degradation, and localization of PIP2 must govern ion channel 
function.
4.1 Lipid mediated localization of PIP2 in the plasma membrane
Phosphoinositides distributes heterogeneously in the plasma membrane [85–87]. 
Hydrophobicity causes lipids to partition (see Fig. 5). Saturated lipid chains partition into 
cholesterol rich lipid rafts, often referred to as detergent resistant membranes (DRMs). 
Lipids with unsaturation partition into the liquid disordered phase (Ld). Mass spec of resting 
cells indicate that PIP2 is comprised of a polyunsaturated fatty acyl chain [88–90] and 
localizes in the Ld region of the membrane [87]. Quantitative studies of PIP2 suggest close 
to 85% of PIP2 is polyunsaturated and 70% comprised of an arachidonyl acyl chain [90]. In 
contrast, PIP3 is primarily comprised of saturated or monounsaturated lipid acyl chains [89]. 
Strikingly, arachidonyl PIP3 was not detected in quiescent cells [89]. Based on standard 
lipid partitioning, the saturated PIP3 is likely located in cholesterol rafts. In agreement with 
this arrangement, PI3 Kinase (the enzyme that generates PIP3 from PIP2) localizes to lipid 
rafts [91]. Taken together, these data indicate an acyl chain based localization of PIPs in the 
plasma membrane. Figure 4 shows a hypothetical layout of the quiescent cell based on 
available, but limited, mass spec, super resolution imaging, and localization studies [87–90].
4.2 GPCR signaling through lipases
Famously, Gq coupled GPCRs (guanine nucleotide coupled receptors) hydrolyze PIP2 
through phospholipase C (PLC) activation. G protein mediated PIP2 hydrolysis was known 
more than 30 years ago [92]. However, most cell biologist viewed (and many still do) PIP2 
as little more than a substrate for second messenger signaling [93]. This view is inadequate 
for Kir channels; PIP2 must also be viewed as an ion channel activator [3,6] or agonist. 
Hence, hydrolysis of PIP2 by M1 muscarinic receptors should be viewed as a direct 
regulatory mechanism to deplete agonist. PIP2 hydrolysis inactivates both high and low 
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affinity Kir channels [58,59]. Downstream modulation of Kir by phosphatases and kinases 
appear secondary to this direct PIP2 regulation [6,94], a rational also supported by the 
central and highly conserved role of PIP2 in channel activation as described above (2.5). 
PLC regulation of Cav [70], Kir [95], HCN [96], Kv7 [27], K2P [97], and TRP [98,99] 
channels (among others) is well-documented.
In addition to PLC, GPCR signaling activates phospholipase D [100] (PLD). PLD produces 
PA and free choline. PA has emerged as an important signaling lipid [101]. PA and PIP2 
appear to synergistically activate Kir [44] and K2P [102] channels, in contrast the nAChR 
[39] and some Kv [69] respond specifically to PA and not PIP2. A third important class of 
lipases phospholipase A2 (PLA2) also exhibits GPCR regulation [103]. PLA2 hydrolyzes 
arachidonyl-lipids creating lysophospholipids and arachidonic acid. Downstream and second 
messenger signaling are well studied for PLA2 and PLC and include the arachidonic cascade 
and IP3 second messenger signaling respectively. In comparison the upstream role of the 
intact bioactive arachidonyl-phospholipids and PIP2 is much less understood. Nonetheless, 
the added role of PIP2 in directly gating ion channels solidifies a direct rout for GPCR 
regulation of ion channels independent of downstream kinases and calcium signaling [6,94].
Several ion channels bind G-proteins directly, this role is widely accepted for the G-protein 
regulated inward rectifiers (GIRK/Kir3.x) and N-type calcium channels (Cav2) [104]. A 
trimeric complex of GIRK with Gβγ (a G-protein) and PIP2 revealed the GIRK/Gβγ 
interface [40]. And biochemical studies suggest that Gβγ is important for increasing binding 
of PIP2 to GIRK [41]. The precise mechanism by which Gβγ enhances PIP2 activation needs 
further clarification.
4.3 Protein mediated localization of lipid modifying enzymes
Lipases localize with ion channels to increase the speed and specificity of PIP2 channel 
gating [98,105]. For example rhodopsin activated PLC hydrolyzes PIP2 opening TRPL 
channels. Colocalization of PLC with TRPL [98] allows for a fast 20ms response time [106]. 
And TRPM7 directly binds PLC to locally affect channel activation [94]. PLC functionally 
colocalized with NMDA receptors [78] and the IP3 receptor co-localizes with PLC to 
regulate calcium release [107]. PLD lipases directly localize to ion channels, including 
TRPM8 [108] and TREK-1 [109]. There are many subtypes of lipases; their diverse 
regulation and specific localization satisfies cells with the needed diversity for signaling.
4.4 Transient PIP2 signaling
The partitioning of PIPs and their modifying enzymes appears primed to deliver dynamic 
cell signaling. During a signaling event, G-proteins control PIP kinases, lipases, and 
phosphatases, to degrade PIP2 signaling. This signaling generates lipid degradation products 
(Fig. 5B). For example, it was shown PLC activation generates arachidonyl-diacyl-glycerol 
[90]. And PLA2 activation removes the arachidonyl sn2 acyl chain generating lysoPIP2 
[110]. In order to return to a resting state, degradation products need to be removed from the 
membrane and PIP2 resynthesized.
Endocytosis recycles lipid micro domains and lipid rafts after signaling [111]. The late 
endosome and ER feed back into PIP2 signaling. This postsynaptic lipid reuptake would 
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then reset the membrane for another signaling event analogous to presynaptic 
neurotransmitter reuptake. Further studies are needed to understand the temporal and spatial 
regulation of PIP2 in vivo in particular during a signaling event. However, signaling lipids 
are known to control the ion channel desensitization [19], voltage dependence [75], and 
recovery from inactivation [94], and these events correlate with ion channel rundown. Lipid 
regulated desensitization may prove to be a central function of many channel types. Much 
more data is needed to build a complete picture.
4.5 Other mechanistic considerations
Lipids localize topically by leaflets generating a lipid signal. For example 
phosphatidylserine (PS) is found on the inner leaflet of the plasma membrane. Enzymes 
known as flippases and floppases move lipids between leaflets [112]. PS signals by flipping 
outside the cell [113]. PS is negatively charged and movement outside the cell has the ability 
to change the membrane surface charge from negative inside to negative outside. Recently, 
asymmetric changes to the charge of lipids in a bilayer dramatically shifted the voltage 
midpoint potential of a Kv channel[69]. Hence lipids may “flip” as a rapid mechanism to 
impose a lipid induced change on the cell membrane potential, a mechanism that would have 
likely preceded a synapse.
In a separate mechanism, lipid acyl transferases (LAT) could signal to ion channels by 
changing the unsaturation of a lipid acyl chain. LAT enzymes add acyl chains to lipids or 
move acyl chains between existing lipids [114]. If a LAT enzyme swaps an arachidonyl acyl 
chain with a saturated one, the signaling lipid would most likely translocate to a lipid raft 
(Fig. 5). This may simply sequester the signal away from the ion channel by moving the 
lipid into or out of a lipid micro domain. Alternatively, the translocation could make the 
lipid available to other modifying enzymes that would then deplete the signal from the 
membrane.
Or, lipid acyl chains may directly contribute to gating of an ion channel. The acyl chains 
contain chemical diversity and putative specificity could determine the affinity of the lipid 
for the channel or cause a specific conformational change that gates the channel. 
Hydrophobic sites for lipid acyl chains affect PIP2 activation of Cav2.2 [11].
The four identical binding sites in Kir are positioned for PIP2 cooperatively and allosteric 
competition. Tetrameric channels engineered to have only one binding pocket indicated that 
one PIP2 molecule is sufficient to activate the channel [66]. In wild type channels with four 
binding sites, PIP2 in combination with PA, PG, or PS, dramatically increased channel 
conductance. However, absent PIP2, these lipids failed to activate Kir [44]. A structure of Kir 
with PA bound showed PA binding to the canonical PIP2 site [10]; a site also compatible 
with PG and PS. In biochemical studies, oleoyl-CoA, an endogenous inhibitor, also 
competes directly with PIP2 [52]. Taken together, these studies suggest that in Kir the lipid 
binding site is always occupied, and Kir integrates the sum total of the lipid environment in a 
cooperative way. At least one site must be occupied by PIP2; the remaining three canonical 
sites appear to be available to exert cooperative activation or inhibition through a rigid 
conformational change [10] in the CTD. Thus additional PIP2 binding events are poised to 
activate Kir with increasing affinity consistent with electrophysiology recordings [66].
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Lastly, the relative abundance of diet-derived fatty acids may affect the levels of PIP2 
signaling in the plasma membrane. Cells appear to incorporate the relative amounts of 
saturated and unsaturated fats into their cell membranes (phospholipids) [115]. It is tempting 
to speculate that diets with excess saturated fat would lead to saturated PIP2 signaling, 
which most likely favors PIP3 signaling. Diets with large amounts of polyunsaturated fats 
(PUFAs) would lead to more arachidonyl-PIP2 and more PIP2 signaling. This may account 
for the positive affect of dietary PUFAs on heart arrhythmias and insulin resistance since 
PIP2 channels (including Kir) are central to both these diseases. Consistent, with this model, 
loss of PIP2 channel activation is associated with the disease states [61]. Similar speculation 
could be made of chronic pain and perhaps some cancers. Understanding PIP2 acylation may 
shed light on these important medical problems.
5. The future of lipid Ion channel interactions
5.1 Pharmacology of lipids
Better methods are needed for assaying lipid interactions with ion channels. Most studies 
rely on crude pharmacological shifts of PIP2 concentrations in biological membranes; this is 
inadequate. Varying the concentration of lipids in a liposome is a good step in the right 
direction. Normally one describes a ligand in terms of an on and off rate. Certainly lipids 
have an affinity for ion channels, but we lack the methodology for effectively measuring 
lipid channel interactions. Better quantitative lipid binding assays are needed. New mass 
spec techniques will likely allow for quantitative measurements of lipids in vivo and in vitro. 
And there is no doubt lipidomics will continue to find ways to improve the quantitative, 
temporal, and spatial identification of lipids in a membrane.
5.2 Implications on the plasma membrane
The plasma membrane holds thousands of lipids with functions that remain largely a 
mystery [116]. A catalog of lipid signals appears poised to exert exquisite regulation on 
membrane proteins perhaps rivaled only by protein phosphorylation. Certainly the 
phosphodiester bonds in lipids are equally suited for rapid signaling. And lipid acyl chains 
may be as diverse in function as they are in chemistry. Recognizing low abundant 
phospholipid signaling molecules as potential ligands for membrane proteins reveals a vast 
pool of putative effector ligands for cellular signaling.
6. Concluding remarks
The added role of PIP2 activation presented here takes shape from the recent 
crystallographic Kir structures. The non-specific model of PIP2 activating Kir is gradually 
making room for a PIP2 site with specificity and ligand like properties. How does a lipid 
ligand influence its target molecule? It does so just like any other molecule; it binds in a 
concentration dependent manner to a binding site and elicits a conformational change in the 
protein. While in hindsight this seems an obvious possibility, the plasma membrane has 
always been a little mysterious [117] and the understanding of membrane proteins slow in 
coming. No doubt lipid modulation of proteins is diverse with more surprises yet to come.
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Abbreviations
AA arachidonic acid
ASIC acid sensing ion channel
ATP adenosine triphosphate
BK big conductance potassium channel
Cav voltage-dependent calcium channel or VDCC





DRM detergent resistant membrane
ER endoplasmic reticulum
GIRK G-protein inward rectifying potassium channel or Kir3
Gβγ G-protein beta gamma subunit
GPCR G-protein coupled receptor
HCN hyperpolarization-activated cyclic nucleotide-gated
IP3 inositol triphosphate
Katp ATP- sensitive potassium channel or Kir6
Kir inward rectifying potassium channel
Kv voltage-gated potassium channel
K2P two pore domain potassium channel
LAT lipid acyl transferase
Ld liquid disordered phase
MARCKS myristoylated alanine-rich C-kinase substrate
Mg magnesium
NMDA N-methyl-D-aspartate receptor
nAChR nicotinic acetylcholine receptor
PA phosphatidic acid
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PTEN phosphatase and tensin homolog
PUFA polyunsaturated fatty acid
P2X purinergic receptors
Sn2 stereospecific numbering position 2 or the second hydroxyl group of 
glycerol
TMD transmembrane domain
TM1 transmembrane helix 1
TREK TWIK related potassium channel or K2P2.1
TRP transient receptor potential channel
VSD voltage sensor domain
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• Membrane resident lipids bind to and activate ion channels with ligand like 
properties.
• Inward rectifier potassium channel Kir2.2 is a PIP2 lipid-gated ion channel
• Lipid microdomains compartmentalize lipid signals.
• Lipases and endocytosis terminate lipid signaling to ion channels.
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PIP2 lipid regulation of ion channels. A, The chemical structure of plasma membrane PIP2 is 
shown with an arachidonyl acyl chain (green) and inositol phosphates at the 4′ and 5′ 
position (red). B, a cartoon representation of a PIP2 lipid gated ion channel. PIP2 is shown 
bound to a lipid binding site in the transmembrane domain of an ion channel. C, List of ion 
channels with lipid gating properties. Kir2.2 and 3.2 are the most clearly “lipid-gated”. A 
second group appears to be dual regulated, or “PIP2 modulated”. PIP2 modulates channel 
gating, but gating also requires either voltage or a second ligand. A third group of channels 
behave similar to Kir but await definitive proof of lipid gating vs. PIP2 modulation (?). The 
list of channels is exemplary and not comprehensive.
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Conserved PIP2 binding site in Kir2.2. PIP2 binds the transmembrane domain (TMD) of Kir 
and causes a conformational change that allosterically gates the channel. A, The PIP2 
binding site is specific for inositol 5′ phosphate. B, A sequence alignment of all Kir family 
members reveals a highly structured PIP2 binding site comprised of basic residues. Amino 
acid residues that directly contact PIP2 are shown in bold type. Only two residues (brown 
type) at the conserved site lack a positive charge. Residues originating from the TMD and a 
linker (LNK) are shaded green and grey respectively. ^ indicates residues that strongly 
coordinate the lipid backbone phosphate, * indicates the residues that strongly (red) and 
weakly (grey) bind the PIP2 5′ phosphate. PIP2 atoms are colored yellow, carbon, orange 
phosphate; red oxygen. Amino acid side chains with carbons colored green are located on 
transmembrane outer helix 1 (TM1) or inner helix 2 (TM2). Lysines colored grey are located 
on the start of a linker helix (LNK) or “tether helix” connecting the transmembrane domain 
(TMD) and the cytoplasmic domain (CTD). Residue numbering is according to Kir2.2.
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Mechanistic comparison of surface charge gating vs. direct lipid gating. A, Non-specific 
surface charge gates an ion channel through a charge sensor domain (blue). The vertical 
arrow indicates charge driven movement. B, A lipid-gated channel reversibly binds the 
signaling lipid PIP2 to allosterically gate the channel. A horizontal arrow indicates PIP2 
dissociation from the channel.
Hansen Page 21














Phosphoinositide (PI) partitioning in the plasma membrane. In the absence of a stimulus, 
arachidonyl-PIP2 (green) localizes in the disordered region of the plasma membrane and 
sometimes in concentrated lipid micro domains (dark green) apart from cholesterol-rich 
lipid-rafts (red). Inositol lipids are distributed according to their acyl chains; hence, saturated 
PIP2 enters lipid rafts where PI3 kinase generates PIP3. A saturated lysoPIP2 may also 
associates with raft like domains. Key signaling enzymes (see colored boxes) appear 
localized in lipid micro domains where they are optimally positioned to remodel the PIP 
acyl chains and head groups during signaling. Lipid degradation products are found in 
endocytic vesicles, which suggest a lipid-recycling event analogous to recycling of some 
soluble neurotransmitters. Grey diamond represents PI3 kinase.
Hansen Page 22














PIP2 transient signaling. A, In the proposed model, PIP2 dissociates from Kir and diffuses 
laterally in the plasma membrane. G proteins activate lipid-hydrolyzing enzymes that 
deplete PIP2 from the plasma membrane or laterally redistribute PIP2 into distinct lipid 
micro domains (e.g. lipid rafts). Dynamic PIP2 signaling gives rise to a transient inactivation 
of Kir that contributes to an action potential. B, PIP2 degradation products are taken up by 
endocytosis and PIP2 resynthesis returns the cell to a resting state.
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Insositolphosphate ion channel specificity
Channel PIP2 effect Selectivity over Comments Ref
TRPM8 Activation* PI(3,4)P2 and PIP3 5′ activates, 3′ inhibits [19,43]
TRPV1 Mixed PI(4)P and PIP3 Likely acyl chain dependence [42,71]
TRPM4 Activation PI(4)P and PI(5)P Modest selectivity over PIP3 [75]
P2X4 Activation PIP3 Modest selectivity over PIP3 [77]
TRPML Inhibition PI(3,5)P2 (activation) Direct competition of (3,5) with PI(4,5)P2 [72,73]
Kir2.1,1.1 Activation* PI(3,4)P2 (inhibition) Direct competition of (3,4) with PI(4,5)P2 [20,52]
Kir3 (Girk2/4) Activation* PI(4)P Gbg increases PI(4,5)P2 binding [20]
*
PIP2 is known to be necessary and sufficient for channel activation.
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